Possible Bullish Engulfing Pattern Detected for Chelsea Therapeutics ... Financial tidings Network Online The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis , and another disorders. Chelsea Therapeutics global has overhead space with shares priced $3.91, ... and more » Link To Article
No comments:
Post a Comment